CHEK2, which is essential for genomic stability [27], is known to be a multiorgan cancer susceptibility gene and is frequently analysed in tumour diagnostics, e.g. of breast, colorectal and prostate cancer [61,62]. Here, CHEK2 is linked to prostate carcinoma.